Kavita Y Sarin

26PUBLICATIONS
133CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 13, 2026
New Approaches to Clinical Trials for Rare Diseases: Decentralized Trial Design for Neurofibromatosis Type 1 and Schwannomatosis.

|Dec 29, 2025
Dissection of Gαs and Hedgehog Signaling Cross-talk Reveals Therapeutic Opportunities to Target Hedgehog-Dependent Tumors.

Sarah Krantz, Braden A Bell, Katherine Lund

|Sep 17, 2024
Multiomics Profiling Distinguishes Sebaceous Carcinoma from Benign Sebaceous Neoplasms and Provides Insight into the Genetic Evolution of Sebaceous Carcinogenesis.

Gabriel J Starrett, Brittany C Baikie, Benjamin K Stoff

|May 01, 2024
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.

Kavita Y Sarin, Mark Bradshaw, Chris O'Mara

|Apr 10, 2024
Noninvasive virtual biopsy using micro-registered optical coherence tomography (OCT) in human subjects.

Yonatan Winetraub, Aidan Van Vleck, Edwin Yuan

|Oct 11, 2023
Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma.

Kavita Y Sarin, John Kincaid, Brittney Sell

Pageof 5

Frequent Collaborators

4 joint publications

Anthony E Oro

4 joint publications

Scott X Atwood

3 joint publications

Scott R Plotkin

3 joint publications

Kerri Rieger